Find and Pitch Jounalists, Get Your Story Covered

Tags: leadership pharma Research & Development research-development biotech

	Profile	Recent Articles on Subject
1	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The biotech news you missed this week - 19 days ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 2 months ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 7 months ago FDA chastens pet companies over antibiotics - 7 months ago The biotech news you missed from the weekend - 8 months ago Novartis is building a new radioligand plant in China - 8 months ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Up-and-comers look for an edge in the bustling ADC field - 29 days ago Pharma’s R&D gamble: picking pipeline winners in a risky field - about 2 months ago Where competition is heating up in pharma - 2 months ago Astellas’ science chief on the leap into new technologies - 6 months ago The biggest questions hanging over pharma in 2024 - 6 months ago Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention - 6 months ago Pharma execs sound off on trends and policies they’re tracking in 2024 - 7 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - 7 months ago Does BioMarin’s CEO shuffle signal bigger changes ahead? - 9 months ago PharmaVoice 100s: Entrepreneurs - 9 months ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - 9 months ago PharmaVoice 100s: Clinical trial gurus - 9 months ago
3	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Ahead of its upcoming decision date, a competitor takes aim at KarXT - about 1 month ago Behind the powerful computations, AI’s role in pharma is still beset by challenges - about 1 month ago 4 offbeat biotechs making a splash in the life sciences - 3 months ago How a biotech exec is leveraging Big Pharma lessons to advance tRNA - 3 months ago As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene - 4 months ago These biotech hotspots are ripe for IPOs - 5 months ago Black Diamond looks to outwit cancer mutations - 5 months ago
4	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	A biotech’s binary bet ends badly - about 1 month ago
5	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 4 months ago STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 7 months ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - 7 months ago STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - 7 months ago STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors - 7 months ago STAT+: Pharmalittle: Pfizer is leaving the BIO trade group; CVS drug-pricing plan may not lower costs for consumers - 8 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - 8 months ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - 9 months ago STAT+: Pharmalittle: Life sciences deals on track to hit lowest point since 2017; EU regulators order Illumina to divest Grail - 10 months ago
6	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	Gas prices are hurting biotech - 4 months ago BioMarin appeases an activist - 7 months ago STAT+: 3 trends to watch in biotech in 2024 - 7 months ago Legend Biotech’s deal with Novartis is a reminder that biotech’s bear market has a few haves, and many have-nots - 9 months ago
7	Alex Carchidi Motley Fool Writer, consultant, entrepreneur. Motley Fool. Boston, Massachusetts writingconsultingentrepreneurshipfinance	3 Biopharma Stocks You Don't Want to Miss in the New Bull Market - 5 months ago
8	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships - 5 months ago STAT+: Biotech incubator Curie.Bio graduates its first startup - 9 months ago
9	Alexandra Pecci Pharma Voice Leading community for life sciences leaders. Washington, D.C. pharmaceuticalslife sciencescommunity building	Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health - 5 months ago 4 biotechs to watch in 2024 - 5 months ago 5 noteworthy pharma AI investments in 2023 - 7 months ago The fortunes and flops of pharma M&A - 8 months ago Biopharma’s top 5 IPOs of 2023 (so far) - 8 months ago The power of genomics-based healthcare remains largely untapped - 8 months ago 5 of the best paid biopharma CEOs - 9 months ago In a record year for biotech bankruptcy, here are 3 companies that went under - 9 months ago Cidara’s J&J-partnered immunotherapy could target flu and cancer - 9 months ago To close the pediatric innovation gap, this biotech has to think differently - 10 months ago
10	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: Novartis to buy German biotech MorphoSys for $2.9 billion - 6 months ago

Journalists covering biopharma